Felicia C Chow1, Richard W Price2, Priscilla Y Hsue3, Anthony S Kim2. 1. Department of Neurology, University of California, San Francisco, San Francisco, California. Electronic address: felicia.chow@ucsf.edu. 2. Department of Neurology, University of California, San Francisco, San Francisco, California. 3. Department of Medicine (Division of Cardiology), University of California, San Francisco, San Francisco, California.
Abstract
BACKGROUND: Although ischemic stroke risk is increased among people living with HIV infection, little is known about the epidemiology of ischemic stroke subtypes in contemporary HIV-infected cohorts. We examined the distribution of ischemic stroke subtypes among predominantly treated HIV-infected individuals to determine if and how the distribution differs from that of the general population. METHODS: We studied 60 HIV-infected and 60 HIV-uninfected adults with a history of first-ever ischemic stroke between 2000 and 2012. Ischemic strokes were classified as 1 of 5 subtypes based on established criteria. We used multinomial logistic regression models to compare the relative frequency of ischemic stroke subtypes by HIV status. RESULTS: Large artery atherosclerosis (23%) and stroke of undetermined etiology (23%) were the most common stroke subtypes among HIV-infected individuals. The most recent plasma HIV viral load before the stroke event differed by subtype, with a median undetectable viral load for individuals with large artery stroke and stroke of undetermined etiology. Using cardioembolic stroke as the reference subtype, HIV-infected individuals were at higher proportional risk of stroke of undetermined etiology compared with uninfected individuals (relative risk ratio [RRR]: 8.6, 95% confidence interval [CI]: 1.2-63.7, P = .04). Among HIV-infected individuals with virologically suppressed infection, we observed a trend toward a greater proportion of strokes attributable to large artery atherosclerosis (RRR: 6.7, 95% CI: .8-57.9, P = .08). CONCLUSIONS: HIV-infected individuals may be at greater proportional risk of stroke of undetermined etiology compared with uninfected individuals. Further investigation is warranted to confirm this finding and determine underlying reasons for this greater risk.
BACKGROUND: Although ischemic stroke risk is increased among people living with HIV infection, little is known about the epidemiology of ischemic stroke subtypes in contemporary HIV-infected cohorts. We examined the distribution of ischemic stroke subtypes among predominantly treated HIV-infected individuals to determine if and how the distribution differs from that of the general population. METHODS: We studied 60 HIV-infected and 60 HIV-uninfected adults with a history of first-ever ischemic stroke between 2000 and 2012. Ischemic strokes were classified as 1 of 5 subtypes based on established criteria. We used multinomial logistic regression models to compare the relative frequency of ischemic stroke subtypes by HIV status. RESULTS: Large artery atherosclerosis (23%) and stroke of undetermined etiology (23%) were the most common stroke subtypes among HIV-infected individuals. The most recent plasma HIV viral load before the stroke event differed by subtype, with a median undetectable viral load for individuals with large artery stroke and stroke of undetermined etiology. Using cardioembolic stroke as the reference subtype, HIV-infected individuals were at higher proportional risk of stroke of undetermined etiology compared with uninfected individuals (relative risk ratio [RRR]: 8.6, 95% confidence interval [CI]: 1.2-63.7, P = .04). Among HIV-infected individuals with virologically suppressed infection, we observed a trend toward a greater proportion of strokes attributable to large artery atherosclerosis (RRR: 6.7, 95% CI: .8-57.9, P = .08). CONCLUSIONS:HIV-infected individuals may be at greater proportional risk of stroke of undetermined etiology compared with uninfected individuals. Further investigation is warranted to confirm this finding and determine underlying reasons for this greater risk.
Authors: David B Hanna; Wendy S Post; Jennifer A Deal; Howard N Hodis; Lisa P Jacobson; Wendy J Mack; Kathryn Anastos; Stephen J Gange; Alan L Landay; Jason M Lazar; Frank J Palella; Phyllis C Tien; Mallory D Witt; Xiaonan Xue; Mary A Young; Robert C Kaplan; Lawrence A Kingsley Journal: Clin Infect Dis Date: 2015-04-22 Impact factor: 9.079
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck Journal: AIDS Date: 2019-02-01 Impact factor: 4.177
Authors: Felicia C Chow; Andrew Callen; Victor Arechiga; David Saloner; Jared Narvid; Priscilla Y Hsue Journal: AIDS Date: 2022-01-01 Impact factor: 4.177
Authors: Yair Mina; Tianxia Wu; Hsing-Chuan Hsieh; Dima A Hammoud; Swati Shah; Chuen-Yen Lau; Lillian Ham; Joseph Snow; Elizabeth Horne; Anuradha Ganesan; Stanley I Rapoport; Edmund C Tramont; Daniel S Reich; Brian K Agan; Avindra Nath; Bryan R Smith Journal: Neurology Date: 2021-02-26 Impact factor: 9.910
Authors: Barbara N Harding; Tigran Avoundjian; Susan R Heckbert; Bridget M Whitney; Robin M Nance; Stephanie A Ruderman; Rizwan Kalani; David L Tirschwell; Emily L Ho; Kyra J Becker; Joseph Zunt; Felicia Chow; Andrew Huffer; W Christopher Mathews; Joseph Eron; Richard D Moore; Christina M Marra; Greer Burkholder; Michael S Saag; Mari M Kitahata; Heidi M Crane; Joseph C Delaney Journal: Epidemiology Date: 2021-05-01 Impact factor: 4.860
Authors: Tecla M Temu; Jerry S Zifodya; Stephen J Polyak; Jessica Wagoner; Celestine N Wanjalla; Sarah Masyuko; Jerusha Nyabiage; John Kinuthia; Gerald S Bloomfield; Stephanie T Page; Carey Farquhar Journal: AIDS Date: 2021-01-01 Impact factor: 4.632